Amgen Stock News

Bogart Wealth LLC increased its position in Amgen Inc. (NASDAQ:AMGN) by 34.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,207 shares of the medical research companys stock after purchasing an additional 2,852 shares during the period. Bogart Wealth []

Equities analysts predict that Amgen Inc. (NASDAQ:AMGN) will announce $6.90 billion in sales for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Amgens earnings, with estimates ranging from $6.74 billion to $6.98 billion. Amgen posted sales of $6.63 billion in the same quarter last year, which would indicate a positive []

Insight Folios Inc bought a new stake in Amgen Inc. (NASDAQ:AMGN) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,807 shares of the medical research companys stock, valued at approximately $384,000. A number of other institutional investors also recently bought and sold shares of []

Courier Capital LLC boosted its holdings in Amgen Inc. (NASDAQ:AMGN) by 0.2% during the third quarter, Holdings Channel reports. The institutional investor owned 41,235 shares of the medical research company’s stock after buying an additional 102 shares during the period. Amgen makes up 0.8% of Courier Capital LLC’s portfolio, making the stock its 29th biggest […]

Intelligence Driven Advisers LLC bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN) during the 3rd quarter, HoldingsChannel.com reports. The firm bought 1,269 shares of the medical research companys stock, valued at approximately $269,000. A number of other large investors have also recently made changes to their positions in AMGN. Miracle Mile Advisors LLC []

Intelligence Driven Advisers LLC bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN) during the 3rd quarter, HoldingsChannel.com reports. The firm bought 1,269 shares of the medical research companys stock, valued at approximately $269,000. A number of other large investors have also recently made changes to their positions in AMGN. Miracle Mile Advisors LLC []

Bone Degeneration Therapeutics is the use of injected nutrients to promote bone growth and repair in sickle cell disease patients. Sickle Cell Disease is a hereditary blood disorder that causes the blood cells to be made primarily from a protein

Canton Hathaway LLC decreased its position in Amgen Inc. (NASDAQ:AMGN) by 15.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,541 shares of the medical research companys stock after selling 2,125 shares during the period. Amgen makes up 0.7% []

WESPAC Advisors SoCal LLC lowered its stake in Amgen Inc. (NASDAQ:AMGN) by 58.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,222 shares of the medical research company’s stock after selling 20,180 shares during the period. WESPAC Advisors SoCal LLC’s holdings […]

Key Companies for Global CAR-T Cell Therapy Market Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc, Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, Celgene Corporation And More Key Companies for Global CAR-T Cell Therapy Market Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc, Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, Celgene Corporation And More

Global Small Molecule Sterile Injectable Drugs Market Overview: A brilliant Small Molecule Sterile Injectable Drugs Market research report brings into focus the key market dynamics of the sector. This market study also analyzes the market status, market share, growth rate, future

THOUSAND OAKS, Calif., Nov. 24, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Evercore ISI Healthcare Conference at 5:10 p.m. ET on Tuesday, Nov. 30, 2021. Rob Lenz, M.D., Ph.D.

Burns J W & Co. Inc. NY raised its holdings in Amgen Inc. (NASDAQ:AMGN) by 2.3% during the third quarter, Holdings Channel reports. The institutional investor owned 25,437 shares of the medical research companys stock after buying an additional 562 shares during the quarter. Burns J W & Co. Inc. NYs holdings in Amgen were []

Northwest Bancshares Inc. raised its stake in Amgen Inc. (NASDAQ:AMGN) by 5.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,432 shares of the medical research company’s stock after buying an additional 1,153 shares during the quarter. Northwest Bancshares Inc.’s holdings […]

San Diego-based company plans to develop medications for neurological disorders Related Stocks: NBIX , SOLTF , LLY , PFE , MRK , BMY , AZN , GSK , AMGN , SNY , FRA:SNY , STU:SNY ,